Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model

Neuroscience Letters

Volumn 413, Issue 3, 2007, Pages 265-269

  Park, Jong Ha ^a   Hong, Yoon Ho ^a   Kim, Hyun Jung ^a   Kim, Sung Min ^a   Kim, Min Jeong ^a   Park, Kyung Seok ^a   Sung, Jung Joon ^a   Lee, Kwang Woo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Amyotrophic lateral sclerosis; Copper zinc superoxide dismutase; G93A transgenic mice; Pyruvate; SOD1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PROTEIN BCL 2; PYRUVIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; DRUG MECHANISM; GLIOSIS; IMMUNOREACTIVITY; LIFESPAN; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLIOSIS; MICE; MICE, TRANSGENIC; PSYCHOMOTOR PERFORMANCE; PYRUVIC ACID; SPINAL CORD; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS; TYROSINE;

EID: 33846817493     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.11.058     Document Type: Article

References (31)

1. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 40 (1996) C1424-C1437
2. Brown R.H., and Robberecht W. Amyotrophic lateral sclerosis: pathogenesis. Semin. Neurol. 21 (2001) 131-139
3. Cassina P., Peluffo H., Pehar M., Martinez-Palma L., Ressia A., Beckman J.S., Estevez A.G., and Barbeito L. Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J. Neurosci. Res. 67 (2002) 21-29
4. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2 (2001) 806-819
5. Corson L.B., Strain J.J., Culotta V.C., and Cleveland D.W. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6361-6366
6. Desagher S., Glowinski J., and Prémont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17 (1997) 9060-9067
7. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., and Rothstein J.D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52 (2002) 771-778
8. Dupuis L., Gonzalez de Aguilar J.L., Oudart H., de Tapia M., Barbeito L., and Loeffler J.P. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener Dis. 1 (2004) 245-254
9. Dupuis L., Oudart H., Rene F., Gonzalez de Aguilar J.L., and Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 11159-11164
10. Durand J., Amendola J., Bories C., and d'Incamps B.L. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis. J. Physiol. 99 (2006) 211-220
11. Garcia C.K., Goldstein J.L., Pathak R.K., Anderson R.G., and Brown M.S. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle. Cell 76 (1994) 865-873
12. Giandomenico A.R., Cerniglia G.E., Biaglow J.E., Stevens C.W., and Koch C.J. The importance of sodium pyruvate in assessing damage produced by hydrogen peroxide. Free Radic. Biol. Med. 23 (1997) 426-434
13. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., and Deng H.X. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
14. Julien J.P. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104 (2001) 581-591
15. Kim H.J., Kim J.M., Park J.H., Sung J.J., Kim M., and Lee K.W. Pyruvate protects motor neurons expressing mutant superoxide dismutase 1 against copper toxicity. Neuroreport 16 (2005) 585-589
16. Lee J.Y., Kim Y.H., and Koh J.Y. Protection by pyruvate against transient forebrain ischemia in rats. J. Neurosci. 21 (2001) RC171
17. Liu D., Wen J., Liu J., and Li L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J. 13 (1999) 2318-2328
18. Mallet R.T., Sun J., Knott E.M., Sharma A.B., and Olivencia-Yurvati A.H. Metabolic cardioprotection by pyruvate: recent progress. Exp. Biol. Med. 230 (2005) 435-443
19. Maus M., Marin P., Israel M., Glowinski J., and Prémont J. Pyruvate and lactate protect striatal neurons against N-methyl-d-aspartate-induced neurotoxicity. Eur. J. Neurosci. 11 (1999) 3215-3224
20. Mazzio E.A., and Soliman K.F. Cytoprotection of pyruvic acid and reduced beta-nicotinamide adenine dinucleotide against hydrogen peroxide toxicity in neuroblastoma cells. Neurochem. Res. 28 (2003) 733-741
21. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., and Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
22. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. NEJM 344 (2001) 1688-1700
23. Ryu J.K., Kim S.U., and McLarnon J.G. Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease. Exp. Neurol. 183 (2003) 700-704
24. Said Ahmed M., Hung W.Y., Zu J.S., Hockberger P., and Siddique T. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1. J. Neurol. Sci. 176 (2000) 88-94
25. Schutz B., Reimann J., Dumitrescu-Ozimek L., Kappes-Horn K., Landreth G.E., Schurmann B., Zimmer A., and Heneka M.T. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J. Neurosci. 25 (2005) 7805-7812
26. Sheline C.T., Behrens M.M., and Choi D.W. Zinc-induced corticalneuronal death: contribution of energy failure attributable to loss of NAD+ and inhibition of glycolysis. J. Neurosci. 20 (2000) 3139-3146
27. Strong M.J. The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacol. Ther. 98 (2003) 379-414
28. Tsacopoulos M., and Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 16 (1996) 877-885
29. Wang X.F., and Cynader M.S. Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J. Neurosci. 21 (2001) 3322-3331
30. Weydt P., Hong S.Y., Kliot M., and Möller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 14 (2003) 1051-1054
31. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., and Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271 (1996) 515-518